Back to the main directory
Press Release
- Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets by GlobeNewsWire
- Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates by GlobeNewsWire
- Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000 by GlobeNewsWire
- AAP, Inc. Cancels over $2 million in debt by GlobeNewsWire
- Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies by GlobeNewsWire
- AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference by BusinessWire
- DSM: Net Asset Value(s) by GlobeNewsWire
- Crédit Agricole Brie Picardie : Bilan Semestriel du contrat de liquidité du CCI Brie Picardie au 31/12/2022 by GlobeNewsWire
- Blackline Safety Reports Fiscal Fourth Quarter and Year-End 2022 Results – Record Annual Revenue of $73 Million, Up 34% by BusinessWire
- Edible Garden Announces New Distribution with Morton Williams Supermarkets by GlobeNewsWire
- Nayax Provides Q4 and FY 2022 Preliminary Revenue and KPI Data by GlobeNewsWire
- Matrix Service Company Sets Date for Release of Financial Results for the Second Quarter of Fiscal 2023 by GlobeNewsWire
- Announcing the Effective Date of a Make-Whole Fundamental Change by GlobeNewsWire
- Digital Distro, Inc. (OTC: UVSS) Provides Film and Music Production Updates by GlobeNewsWire
- Leading Bitcoin ATM Operator Bitcoin Depot Strengthens U.S. Footprint with New Retail Partnerships by GlobeNewsWire
- MamaMancini’s to Present at the Diamond Equity Research Emerging Growth Invitational on Wednesday, January 25th by GlobeNewsWire
- Clearday Signs a Letter of Intent to Purchase a Property Portfolio and Further Diversify its Revenue Streams by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Biffa plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc by EQS Group AG
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Métaux Osisko annonce de nouveaux résultats de forage au Mont Copper dont 1011,0 mètres titrant 0,46 % de cuivre et 3,19 g/t d'argent by GlobeNewsWire
- iSun Inc. Wins New Solar Portfolio in Maine by BusinessWire
- The Management Board decided to purchase own shares in order to grant them to the employees by GlobeNewsWire
- Leggett & Platt Announces 4Q 2022 Earnings Call by GlobeNewsWire
- Jourdan Hires Roger Lemaitre as Vice-President and Head of Mining by GlobeNewsWire
- NV5 to Host Fourth Quarter and Full Year 2022 Conference Call on Thursday, February 23rd at 4:30pm ET by GlobeNewsWire
- Old National Reports 43% EPS Growth from 3Q22, 10% on an Adjusted Basis¹, Driven by Commercial Loan Growth, Net Interest Margin Expansion and Expense Discipline by GlobeNewsWire
- Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium by GlobeNewsWire
- Wilson ASA: Styret forlenger tilbudsfristen by GlobeNewsWire
- Western Union to Release Fourth Quarter and Full Year 2022 Results on February 7, 2023 by BusinessWire
- Ordinær Generalforsamling RIAS A/S by GlobeNewsWire
- Altamira Therapeutics Provides Update on Clinical Trials with Bentrio by GlobeNewsWire
- Vistagen Announces First Participants Dosed in Phase 1 Clinical Trial of PH10, an Investigational Pherine Nasal Spray for Major Depressive Disorder by BusinessWire
- Apollo Commercial Real Estate Finance, Inc. Announces 2022 Dividend Income Tax Treatment by GlobeNewsWire
- Sotherly Hotels Inc. Announcements Reinstatement of Quarterly Preferred Dividends by GlobeNewsWire
- Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate by GlobeNewsWire
- Genasys Inc. Schedules Fiscal First Quarter 2023 Financial Results and Conference Call for February 9, 2023 by GlobeNewsWire
- Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma by GlobeNewsWire
- Blue Star Foods Highlights Sustainability in New ESG Report by GlobeNewsWire
- Trust Stamp Announces Rapid Customer Adoption of Privacy-First Identity Orchestration Platform; Outpacing Management's Expectations by GlobeNewsWire
- KnowBe4 Announces Preliminary Fourth Quarter 2022 Financial Results by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Devro plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc by EQS Group AG
- Osisko Metals Reports Additional Drill Results at Mount Copper Including 1011.0 Metres Grading 0.46% Copper and 3.19 g/t Silver by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc by EQS Group AG
- Auddia Inc. Announces Launch of faidrRadio, an Exclusive Content Offering Within the faidr App by GlobeNewsWire
- Šiaulių banko valdyba nusprendė supirkti savų akcijų, kurios bus suteiktos darbuotojams by GlobeNewsWire
- Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302 by GlobeNewsWire